Key statistics
On Friday, Solvonis Therapeutics PLC (J4I:FRA) closed at 0.001, 100.00% above the 52 week low of 0.0005 set on Nov 12, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.001 |
|---|---|
| High | 0.001 |
| Low | 0.001 |
| Bid | 0.002 |
| Offer | 0.004 |
| Previous close | 0.001 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 6.81bn |
| Free float | 3.57bn |
| P/E (TTM) | -- |
| Market cap | 16.34m GBP |
| EPS (TTM) | -0.001 GBP |
Data delayed at least 15 minutes, as of Feb 06 2026 07:04 GMT.
More ▼
Announcements
- Expansion of SVN-015 into depression
- US Patent allowance for PTSD discovery programme
- Research and Development Update – Q4 2025
- SVN-015 accepted into US NIDA funded programme
- Total Voting Rights
- Corporate Structure Update and Issue of Options
- Appoints global biopharma leader Paul Carter
- Raises £1.25 Million to Accelerate Programmes
- Half-year Report
- Solvonis secures exclusive CNS collaboration
More ▼
